ABSTRACT
Background Multimorbidity, an important health indicator, is a contributor to and result of health inequity. We sought to determine if gaps in multimorbidity by race and ethnicity are decreasing over time.
Methods Serial cross-sectional analysis of the National Health Interview Survey, 1999–2018. The study included individuals ≥18 years old, categorized by self-reported race, ethnicity, age, and income. The main outcomes were trends in the prevalence of multimorbidity, defined as ≥2 concurrent chronic conditions.
Results The study included 596,355 adults (4.7% Asian, 11.8% Black, 13.8% Latino/Hispanic, and 69.7% White). In 1999, the estimated prevalence of multimorbidity was 5.9% among Asian, 17.4% among Black, 10.7% among Latino/Hispanic, and 13.5% among White individuals. Prevalence increased for all racial/ethnic groups during the study period (P<0.005 for each), with no significant change in the differences between them. In 2018, when compared with White people, multimorbidity was more prevalent among Black individuals (+2.5 percent points [95% CI: +0.5, +4.6]) and less prevalent among Asian and Latino individuals (−6.6 points [-8.8, -4.4] and -2.1 points [-4.0, -0.2], respectively). The estimated prevalence of reporting at least 1, 2, 3, or 4 conditions all increased with age across all groups, with Black individuals having the greatest prevalence in each age category. Among those aged ≥35 years, Black people had multimorbidity rates equivalent to those of Latino/Hispanic and White people aged 5 years older, and Asian people aged 10 years older.
Conclusions Over 2 decades, there was no significant progress in eliminating disparities in multimorbidity between Black and White people.
INTRODUCTION
In 2010, the US Department of Health and Human Services published a public health framework for managing patients with multimorbidity, defined as the presence of 2 or more concurrent chronic conditions in an individual, highlighting the importance of identifying and addressing disparities in its prevalence.1,2 Despite this report, differences in the prevalence of multimorbidity remain understudied. Recent studies indicate that multimorbidity is more prevalent among Black people compared with White people and that its overall prevalence is increasing in the US.3-5 Given the lack of a comprehensive investigation of trends in multimorbidity over the past 2 decades, especially by race and ethnicity, it is unknown if the US has made progress in narrowing the gaps. The examination of trends in multimorbidity has implications about accountability for what the health system in the US has achieved in population health and health equity over the past 20 years, and what it will face in the future.
Accordingly, we describe the 20-year trends in the prevalence of multimorbidity by race and ethnicity, estimating the annual differences between groups. We also evaluate whether the effect of race and ethnicity on multimorbidity prevalence varied by age. Finally, considering that income is related to race and ethnicity and is one of the most critical determinants of health, we stratified the main analyses by income.
METHODS
Data Source
We used data from the annual National Health Insurance Survey (NHIS) from 1999 to 2018. The NHIS is a cross-sectional representative survey of the non-institutionalized population in the US that describes the health conditions, health insurance coverage and utilization, and health behaviors of recipients. The NHIS uses a complex multistage area probability design that accounts for non-response and allows for nationally representative estimates, including for underrepresented groups.6 We obtained the data from the Integrated Public Use Microdata Series Health Surveys (https://nhis.ipums.org/).7 The Institutional Review Board at Yale University exempted the study from review. Author César Caraballo had full access to the data and takes responsibility for the accuracy of the analysis.
Demographic Variables
Race was determined by the participants’ self-reported primary race selection. Latino/Hispanic ethnicity was defined as answering “Yes” to the question, “Do you consider yourself Latino/Hispanic?” Participants were divided into 4 mutually exclusive subgroups: non-Hispanic Asian (Asian), non-Hispanic Black/African American (Black), Latino/Hispanic, and non-Hispanic White (White).
Respondent characteristics included in the analyses were self-reported age, sex, geographic region (Northeast, North Central/Midwest, South, West), and income. Age was also categorized by 5-year groups for stratification and reporting. Consistent with prior NHIS studies, family income was categorized according to its relative percentage of the federal poverty limit from the US Census Bureau8 into middle/high income (≥200% of the federal poverty limit) and low income (<200%).9-11 Other sociodemographic and clinical variables were used to describe the characteristics of the population.
Chronic Conditions
We included 9 chronic conditions that the Centers for Disease Control and Prevention consistently included in the NHIS across the entire study period. These conditions were among those listed by the Department of Health and Human Services Office of the Assistant Secretary of Health conceptual framework for studying multiple chronic conditions.2 We identified individuals with these conditions if they had ever been told by a health care professional that they had diabetes, hypertension, asthma, stroke, cancer, chronic obstructive pulmonary disease (emphysema or chronic bronchitis), or heart disease (coronary artery disease, myocardial infarction, angina, or other heart conditions), or had been told in the past 12 months that they had weak/failing kidneys or any liver condition. Participants were then classified as having 0, 1, 2, 3, or ≥4 chronic conditions. We defined multimorbidity as the presence of ≥2 of the 9 chronic conditions.1,12-14
Study Population
We included individuals ≥18 years old from years 1999 to 2018 of the Sample Adult Core file, which contains responses from an in-depth questionnaire administered to a randomly selected adult from each family. We excluded responses with missing information about chronic conditions.
Statistical Analysis
We summarized the general characteristics of respondents by racial/ethnic group. Then, we estimated the annual multimorbidity prevalence for each group using multivariable logistic regression models adjusting for age, sex, and region (details in Supplementary Methods). To assess the trends in the prevalence of each of the 9 conditions, we used the same approach as for multimorbidity overall.
We subtracted the annual prevalence among White individuals from that year’s prevalence among Asian, Black, and Latino/Hispanic individuals, also constructing SE for the differences, to quantify the racial and ethnic gap. Using these prevalences and gaps, we estimated trends over the study period by fitting weighted linear regression models (details in Supplementary Methods). We also used a z-test to estimate the absolute difference between 1999 and 2018 in the multimorbidity prevalence within each race and ethnic group, and the differences between groups.
To assess if the association between race and ethnicity and multimorbidity differs by income, we replicated the main analysis by income group. Due to high rates of missing income information from non-response, the publicly available NHIS data included multiply imputed income variables for respondents who did not report income. Thus, we followed the recommendations from the National Center for Health Statistics for multiply imputed data analysis (details in Supplementary Methods).15
To evaluate if the association between race and ethnicity and multimorbidity differs by age, we used a logistic regression model with multimorbidity as the outcome, age and race/ethnicity as independent variables, an interaction term between age and race and ethnicity, and adjusting for region and sex. We reported the interaction term odds ratio (OR) for each race and ethnicity group. We replicated this using an ordered logit model and the number of chronic conditions as outcome, age group as the independent variable, and adjusting for region and sex, using this model to estimate the percentage with 0, 1, 2, 3, and ≥4 conditions in each age group by race and ethnicity.
We reported the findings from these analyses based on the approach of Barnett et al.16 for reporting multimorbidity distribution, including a description of dyads of the distribution of concurrent chronic conditions by race/ethnicity using heart disease, diabetes, and cancer as the index conditions and other conditions as comorbidities.
We performed a sensitivity analysis including arthritis in the list of comorbidities using data from 2002 to 2018, the period in which the condition was available and ascertained consistently.
For all analyses, a 2-sided P-value <0.05 was used to determine statistical significance. All analyses were performed using Stata SE version 17.0 (StataCorp, College Station, TX). All results are reported with 95% CIs. All analyses incorporated strata and weights to produce nationally representative estimates using the Stata -svy- command for structured survey data. All person-weights were pooled and divided by the number of years studied, following guidance from the NHIS.17
RESULTS
Of a total of 603,140 adults interviewed, we excluded 112 with missing race and ethnicity information and 119 with missing chronic conditions information. Due to small representation, we also excluded 6673 with ethnicity other than Latino/Hispanic that also did not select a primary race (n=2114) or that primary race as Alaskan Native or American Indian (n=4355) or Other (n=204) (Figure S1). The final study sample comprised 596,236 adults with an estimated mean age of 46.2 [SE, 0.07] years of which 51.8% [95% CI: 51.7, 52.0] were women. Of these, 4.7% (95% CI: 4.6%, 4.8%) identified as Asian, 11.8% (95% CI: 11.5%, 12.1%) as Black, 13.8% (95% CI: 13.5%, 14.2%) as Latino/Hispanic, and 69.7% (95% CI: 69.3%, 70.2%) as White. The overall estimated prevalence of multimorbidity was 19.9% (95% CI: 19.7%, 20.1%), increasing from 15.2% (95% CI: 14.8%, 15.7%) in 1999 to 22.7% (95% CI: 22.1%, 23.4%) in 2018. The general characteristics of the study population are shown in Table 1, Table S1, and Figure S2.
In 1999, the estimated age-, sex-, and region-adjusted prevalence of multimorbidity was 5.9% (95% CI: 4.3, 8.0) among Asian people, 17.2% (95% CI: 17.7, 18.8) among Black people, 10.5% (95% CI: 9.3, 11.7) among Latino/Hispanic people, and 13.2% (95% CI: 12.8, 13.7) among White people (Figure 1). Between 1999 and 2018, the adjusted multimorbidity prevalence increased significantly within each race and ethnicity group (P=0.001 for Black people and P<0.001 for Asian, Latino/Hispanic, and White people). There were no significant changes in the difference between groups (Table 2). In 2018, when compared with the adjusted multimorbidity prevalence among White people (18.7% [95% CI: 18.0%, 19.5%]), the adjusted multimorbidity prevalence among Black people was estimated to be 2.5 percentage points higher (95% CI: 0.5, 4.6; P=0.02), whereas it was lower among Asian and Latino/Hispanic people by 6.6 points (95% CI: -8.8, -4.4; P<0.001) and 2.1 points (95% CI: -4.0, -0.2; P=0.03), respectively. Throughout the study period, the adjusted prevalence of multimorbidity was persistently higher among people with low income than among those with middle/high income, and in 2018 the difference between Black and White people was not significant when stratified by income (Table 2 and Figure S3).
The estimated prevalence of reporting at least 1, 2, 3, or 4 conditions all increased with age across all groups, with Black people having the greatest prevalence in each age category (Figure 2). Among those aged ≥35 years, Black people had rates of multimorbidity equivalent to those of Latino/Hispanic and White people aged 5 years older, and to those of Asian people aged 10 years older (Figure 3A). Notably, the adjusted prevalence of multimorbidity (≥2 concurrent conditions) diverged between Black people and White people among those aged 35 years, reached its maximum difference of 10.1 percentage points (95% CI: 8.2, 12.1) among those aged 60, and converged to reach similar rates among those aged ≥80 (Figure 3B). There were significant racial and ethnic differences in the association between age and prevalence of multimorbidity. Asian, Black, and Latino/Hispanic people had a greater increase in the prevalence of multimorbidity with age compared with White people (multimorbidity*decade of age interaction term OR 1.17 [95% CI: 1.13, 1.20] for Asian, OR 1.04 [95% CI: 1.02, 1.06] for Black, and OR 1.10 [95% CI: 1.08, 1.12] for Latino/Hispanic; P<0.001 for each). Within each racial and ethnic group, people with low income were associated with a higher prevalence of multimorbidity compared with people in the same age group who had middle/high income (Figure S4).
The distribution of chronic conditions among people with a history of heart disease, diabetes, and cancer is shown in Table S2. Comorbidities (understood as concurrent conditions relative to an index condition) of people with a history of heart disease and cancer were more common among Black people. Black people were more likely to have a history of hypertension, heart disease, and diabetes as comorbidities than other conditions, whereas the most common comorbidities among White people were hypertension, heart disease, and cancer. Adjusted annual rates of each of the individual conditions evaluated are shown in Figure S5.
Sensitivity Analysis
Results from our sensitivity analysis, including arthritis in the chronic conditions count (in the years it was available), were mostly consistent with our main results, with some notable differences (Figures S6, S7, S8, and S9). Prevalence of multimorbidity, as expected, was higher.
From 2002 to 2018, the estimated prevalence of multimorbidity was 27.2% (95% CI: 27.0%, 27.5%). In this sensitivity analysis, the difference in the prevalence of multimorbidity between Black and White people decreased significantly from 2002 to 2018 and was not significant in 2018 (Figure S6).
DISCUSSION
From 1999 to 2018, there were increasing rates of multimorbidity and a static racial gap. Multimorbidity rates were higher among Black people compared with Asian, Latino/Hispanic, and White people of the same age range, with differences starting at 35 years and peaking at 60 years. Overall, and within people of the same racial and ethnic group, those with low income experienced a higher burden of multimorbidity. This 20-year period, which corresponded with significant health care investments and dramatic increases in per capita health care costs,18,19 fails to demonstrate meaningful progress in reducing multimorbidity or racial and ethnic disparities in its prevalence.
Studies have reported racial/ethnic disparities but, to the best of our knowledge, this is the first to analyze whether there was improvement during a recent period notable for increased national attention on reducing health disparities. Our findings expand the literature in several ways. First, we found no improvement in the race/ethnicity gap in multimorbidity. The increasing prevalence of multimorbidity occurred almost in parallel across each of the racial and ethnic groups. These findings reveal a lack of progress in narrowing racial/ethnic disparities in health over a 20-year period, despite major nationwide policies aimed to address health disparities.20-23
Second, we found that the racial and ethnic gap was concentrated in the middle age ranges. It is unclear if such age-related divergence in multimorbidity prevalence may be due to a cumulative effect of an earlier life concentration of risk factors that Black people are more likely to be exposed to, such as environmental stressors, smoking, and barriers to health care.11,24,25 The convergence among the elderly, on the other hand, may be explained by a combination of a ceiling effect in chronic conditions and differences in risk of death associated with earlier multimorbidity among Black people. In a longitudinal study of multimorbidity using the Health and Retirement Study, Quiñones et al.26 reported that middle-aged Black people were more likely to die during follow-up than those who identified as another race/ethnicity.
Third, we found that stratification by income level attenuated the disparities. This observation underscores the role of income in health and health disparities,27 which is especially important given the disproportionately large percentage of Black people in the low-income stratum.28
There are some differences between our findings and the results from other studies that have measured multimorbidity using data from the NHIS. First, the overall unadjusted weighted prevalence of multimorbidity in our study (19.9%) was lower than the estimates from others.29-31 This discrepancy is likely due to the inclusion of arthritis in their calculation of multimorbidity, which was inconsistently available across the 20 years of this study. In an exploratory estimation of multimorbidity using data from 2002 to 2018 including arthritis, the overall estimates were consistent with those from previous reports and did not affect the overall findings. Second, our annual estimates of multimorbidity were adjusted for age, sex, and region, which can provide greater insight into disparities by race and ethnicity.
This study has important implications. First, it shows that the public health challenge of multimorbidity is increasing among the 4 largest race and ethnicity groups in the US, underscoring the growing need for preventive measures nationwide. People with multimorbidity experience challenges not only related to their individual conditions but also related to the complexity and costs of managing multiple conditions simultaneously. Multimorbidity is associated with worse health status,32 faster functional decline,33 lower quality of life,32,34 higher mortality,35 higher rates of unmet medical needs,36 and higher health care costs,37,38 and this study shows that the burden has been persistently higher among Black people. Although preventing the development of multimorbidity should be a public health priority, these findings suggest that complementary and targeted strategies are needed for Black people, supporting access to preventive health resources and continuity of care. The observed persistent gap in multimorbidity may be associated with the persistent disparity in access to preventive health care services that Black people experience. In 2018, and despite modest improvements since 1999, Black people were more likely to lack health insurance coverage, to lack a usual source of health care, and to report unmet medical needs due to cost compared with White people.11 Also, stressors derived from race-based discrimination are associated with higher burden of chronic diseases and multimorbidity.39,40 Thus, our findings should be interpreted in the context of vast literature that identifies systemic racism as a fundamental cause of health inequalities through the reinforcement of a racial and ethnic hierarchy that puts Black people at a disadvantage in obtaining access to goods and opportunities necessary for a healthy life. Public health strategies should account for this in the distribution of resources and efforts to prevent the development of chronic conditions over a lifetime.
Our study has several limitations. First, the cross-sectional design prevents us from measuring and comparing the incidence of multimorbidity across the lifetime of an individual by racial and ethnic groups. Second, we used a limited number of chronic conditions based on their availability in the NHIS dataset and we lack information on the severity, complexity, and duration of such conditions, and whether they were active at the time of the interview (e.g., current active cancer or history of cancer). Second, our multimorbidity measure may be an underestimation because the study relied on self-reported conditions that may go underreported due to barriers to access to care—for its diagnosis—and low health literacy. If any, such underreporting more likely affects Black and Latino/Hispanic people because of their higher barriers to health care. Finally, we focused on large racial and ethnic group categories and were underpowered to examine a wider set of racial and ethnic groups.
Conclusions
From 1999 to 2018, multimorbidity in the US increased and Black people persistently had the highest prevalence of multimorbidity, with racial gaps that did not change.
Data Availability
Data from the National Health Interview Survey is publicly available. We obtained the data from the Integrated Public Use Microdata Series Health Surveys.
Sources of Funding
The study was self-funded.
Conflicts of Interest Disclosure
In the past three years, Harlan Krumholz received expenses and/or personal fees from UnitedHealth, IBM Watson Health, Element Science, Aetna, Facebook, the Siegfried and Jensen Law Firm, Arnold and Porter Law Firm, Martin/Baughman Law Firm, F-Prime, and the National Center for Cardiovascular Diseases in Beijing. He is a cofounder of Refactor Health and HugoHealth, and had grants and/or contracts from the Centers for Medicare & Medicaid Services, Medtronic, U.S. Food and Drug Administration, Johnson & Johnson, Foundation for a Smoke-Free World, State of Connecticut Department of Public Health, and the Shenzhen Center for Health Information. Yuan Lu is supported by the National Heart, Lung, and Blood Institute (K12HL138037) and the Yale Center for Implementation Science. She was a recipient of a research agreement, through Yale University, from the Shenzhen Center for Health Information for work to advance intelligent disease prevention and health promotion. Jeph Herrin has had grants and/or contracts from the Centers for Medicare & Medicaid Services, the National Institutes of Health, Mayo Clinic, Yale University, and Mercy Health. Chima Ndumele has had grants from the National Institutes of Health, Robert Wood Johnson Foundation, and the Commonwealth Fund. The other authors have no competing interests to declare.